Egetis Therapeutics
Presence
Egetis Therapeutics is a company listed under the stock ticker EGTX (SE).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Egetis Therapeutics
- Nicklas Westerholm, Chief Executive Officer
- Peder Walberg, Board Member
- Thomas Lönngren, Chairman of the Board
Popular executive movements at Egetis Therapeutics
- Desiree Luthman has joined the company as Vice President Global Regulatory Affairs (posted on November 7 2023).
Create your alert
to follow the executive moves at Egetis Therapeutics.
Biotechnology
Egetis Therapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
- Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
Popular contacts in Biotechnology
News
Press releases by Egetis Therapeutics
- Egetis Therapeutics’ 2023 Annual Report published - Egetis Therapeutics
- NOTICE OF ANNUAL GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL) - Egetis Therapeutics
- Year-End report January-December 2023 - Egetis Therapeutics
- Egetis recruits Laetitia Szaller as General Counsel and Head of Compliance - Egetis Therapeutics
- Egetis highlights recent major milestones, status of ReTRIACt trial and gives a corporate update at Investor Day in Stockholm today - Egetis Therapeutics
- Egetis provides update on disease awareness and the Expanded Access Program for tiratricol (Emcitate) in the USA - Egetis Therapeutics
- Egetis’ Investor Day on December 19: Agenda and Registration Details - Egetis Therapeutics
- Save the Date: Egetis to host Investor Day on December 19, 2023 - Egetis Therapeutics
- Egetis announces exclusive license agreement with Fujimoto to develop and commercialize Emcitate in Japan - Egetis Therapeutics
- Egetis recruits Desiree Luthman as Vice President Global Regulatory Affairs - Egetis Therapeutics
- View more press releases Close
Social media about Egetis Therapeutics
- Egetis Therapeutics on Wikipedia, Google News & Yahoo Finance
- Egetis Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Nicklas Westerholm 
Call Egetis Therapeutics at +46 ...
